Rosemarie Venier

7PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 24, 2026
Whole-genome and transcriptome analysis in relapsed/refractory non-Hodgkin lymphoma: Results from a multicentre precision oncology cohort.

|Aug 08, 2024
Late-onset tumors in rhabdoid tumor predisposition syndrome type-1 (RTPS1) and implications for surveillance.

Yoshiko Nakano, Meryl Acker, Harriet Druker

|Dec 30, 2022
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations.

Anita Villani, Scott Davidson, Nisha Kanwar

|Feb 11, 2022
Evaluation of barriers to referral for cancer predisposition syndromes in pediatric oncology patients in the United States.

Rosemarie E Venier, Robin E Grubs, Elena Kessler

|Jul 24, 2021
Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival.

Nathaniel D Anderson, Yael Babichev, Fabio Fuligni

|Mar 01, 2018
Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcoma.

Timothy McKinnon, Rosemarie Venier, Marielle Yohe

Pageof 2

Frequent Collaborators

2 joint publications

Julia Meade

2 joint publications

Kelly M Bailey

2 joint publications

Federico Comitani

2 joint publications

Mehdi Layeghifard